<DOC>
	<DOCNO>NCT00345787</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy safety BTDS compare placebo subject moderate severe osteoarthritic pain hip knee .</brief_summary>
	<brief_title>Comparison BTDS ( Buprenorphine Transdermal System ) Placebo Osteoarthritic Pain</brief_title>
	<detailed_description>The primary objective study evaluate efficacy safety buprenorphine transdermal system ( BTDS ) compare placebo subject moderate severe osteoarthritic pain hip knee sub-optimal response non-opioid analgesic treatment require opioid analgesic pain control .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Males female age 40 year old . Clinical diagnosis osteoarthritis ( OA ) hip knee . Subjects current past history chronic disease ( ) , addition OA , require frequent analgesic therapy ( e.g . headache , fibromyalgia , gout , rheumatoid arthritis , low back pain , diabetic neuropathy ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Osteoarthritic Pain</keyword>
</DOC>